Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers | Zendy

Claudio Pulito | Zendy; Sabrina Strano | Zendy; Giovanni Blandino | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dihydroartemisinin: from malaria to the treatment of relapsing head and neck cancers

Author(s) -

Claudio Pulito,

Sabrina Strano,

Giovanni Blandino

Publication year - 2020

Publication title -

annals of translational medicine

Language(s) - English

Resource type - Journals

eISSN - 2305-5847

pISSN - 2305-5839

DOI - 10.21037/atm.2020.03.104

Subject(s) - dihydroartemisinin , medicine , head and neck , malaria , oncology , head and neck cancer , artemisinin , plasmodium falciparum , cancer , surgery , pathology

Oncogenomic and Epigenetic Unit, IRCCS, Regina Elena National Cancer Institute, Rome, Italy; SAFU Laboratory, Department of Research, Advanced Diagnostic, and Technological Innovation, IRCCS Regina Elena National Cancer Institute, Rome, Italy Correspondence to: Claudio Pulito. Oncogenomic and Epigenetic Unit, IRCCS, Regina Elena National Cancer Institute, Via Elio Chianesi, 53, 00144, Rome, Italy. Email: claudio.pulito@ifo.gov.it. Provenance and Peer Review: This article was commissioned by the editorial office, Annals of Translational Medicine. The article did not undergo external peer review. Comment on: Chaib I, Cai X, Llige D, et al. Osimertinib and dihydroartemisinin: a novel drug combination targeting head and neck squamous cell carcinoma. Ann Transl Med 2019;7:651.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research